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Abstract
Developmental checkpoints eliminate B cells synthesizing defective immunoglobulin heavy (HC) 
and light (LC) chains. The first checkpoint tests for formation of a VpreB/λ5/µHC-containing 
preB-cell receptor (preBCR) and predicts whether µHCs will bind conventional LCs to form 
membrane IgM. VpreB and λ5 also create a sensing site that interacts with µHC antigen-binding 
region CDR-H3, but whether it plays a role in immunoglobulin repertoire selection and function is 
unknown. On a position-by-position basis, we analyzed the amino acid content of CDR-H3s from 
H chains cloned from living and apoptotic preB cells and from IgG:Antigen structures. Using a 
panel of DH gene-targeted mice, we show that progressively reducing CDR-H3 tyrosine content 
increasingly impairs preBCR checkpoint passage. Counting from cysteine at Framework 3 
position 96, we found that VpreB particularly selects for tyrosine at CDR-H3 position 101, and 
that Y101 also binds antigen in IgG:Antigen structures. VpreB thus acts as an early invariant 
antigen. It selects for particular CDR-H3 amino acids and shapes the specificity of the IgG 
humoral response. This helps explain why some neutralizing antibodies against pathogens are 
readily produced while others are rare.
Summary
In addition to testing for the likelihood of binding to conventional light chain to create a membrane 
IgM, the VpreB component of the surrogate light chain serves an an invariant antigen that selects 
for particular amino acids at specific positions at the center of the immunoglobulin antigen binding 
site, thereby affecting future antigen recognition and antibody production.
Introduction
The genes that encode immunoglobulins are assembled in developing B cells by a series of 
gene segment rearrangement events that begin with Variable (V), Diversity (DH), and 
Joining (J) gene segments at the heavy chain locus to encode a µHC. Progeny cells then 
rearrange a κ or λ light chain gene and the newly formed B cell expresses membrane IgM as 
an antigen receptor (BCR). The process of B cell development is optimized to create a 
highly diverse antibody repertoire. The antigen binding sites of the antibody are formed by 
the juxtaposition of six complementarity determining regions (CDRs), three from the heavy 
and three from the light chain. V and J gene segments are locked into one reading frame, but 
the DH gene segments can rearrange into any one of six different reading frames (RFs), 
during which two rounds of non-templated N nucleotide addition can also occur. Thus, the 
inclusion of a DH makes CDR-H3 the most variable component of the antigen binding site 
and it often plays a key role in antigen recognition.
In order to avoid production of defective H chains, developing B cells must pass through a 
series of quality control (QC) checkpoints that test the integrity and function of their 
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immunoglobulin (1). The first checkpoint occurs during the transition from the early (Hardy 
fraction C) to late (Hardy fraction D) preB cell stage (2) and tests for the ability of a nascent 
µHC to associate with surrogate light chain (SLC) to form a preB cell receptor (preBCR) 
(1). The SLC consists of two non-covalently associated proteins, the VL homologue VpreB 
and the JLCL homologue λ5 (1). Conventional VL contains conserved Framework Region 2 
(FR2) amino acids that associate with H chain FR2 and FR4 (Fig S1) (1, 3) to form a 
supportive scaffold for the HCDRs. VpreB shares several of these amino acids with VL, thus 
the ability of the µHC to form a preBCR predicts that it will ultimately be able to form an 
IgM BCR. PreB cells that fail to form a functional preBCR perish by apoptosis in the bone 
marrow. Unlike conventional L chains, VpreB and λ 5 are invariant, making the preBCR 
checkpoint quite stringent.
In addition to FR2 and FR4, VpreB associates with CDR-H3. The VpreB portion of the 
CDR-H3 sensing site (CDR-H3 SS) contains a set of charged or hydrophilic residues, three 
of which are conserved between human and mouse (R51, D57 and R101). These residues are 
rare or absent in conventional VL (Fig. S1) (4). In this study, we sought to test whether the 
SLC could use VpreB as an invariant surrogate antigen to select for, and hence against CDR-
H3s with a certain content of amino acids (5). If so, such an early selection step would limit 
the preimmune antibody repertoire and could help explain why some immunoglobulin 
antigen binding sites are rare and thus more difficult to elicit after vaccination or infection 
(6).
The global distribution of amino acids in the primary CDR-H3 repertoire is already known 
to be non-random and specifically enriched for tyrosine (7). In part, this bias reflects the 
nonrandom use of individual DH reading frames (8), each of which exhibits a characteristic 
amino acid signature. In the preimmune repertoire, RF1 is the most frequently utilized, RF2 
and RF3 are used less frequently, and the inverted (i) RFs are rarely used (9). RF1 is 
enriched for tyrosine (Fig. S2) (7), RF2, RF3, iRF2 and iRF3 are enriched for hydrophobic 
amino acids, and iRF1 is enriched for charged amino acids. RF3 tends to contain termination 
codons, limiting its use and thus the presence of leucine in CDR-H3.
The reduced use of RF2 encoded amino acids in mice has been attributed to the presence of 
an upstream ATG codon in-frame with RF2 as a translation start site (8), which results in 
production of a truncated protein product of DJ rearrangement termed Dµ. Although lacking 
the VH component of the H chain, Dµ can associate with the SLC to create a ‘sterile’ 
preBCR that prevents further development. However, this blockade is not absolute and one-
fifth of in-frame VDJ rearrangements in early preB cells use RF2 (10, 11).
Four RF1 CDR-H3 tyrosines (Y101-Y104), each of which can interact with CDR-H3 SS 
amino acids by means of hydrogen bonds, potentially stabilizing the complex, are observed 
in the only published preBCR crystal structure (PDB: 2H32) (4). Since RF2 does not encode 
such tyrosines, we postulated that the halving of RF2 usage that marks passage through the 
preBCR checkpoint (10, 11) might reflect reduced stability of preBCRs containing RF2 
encoded amino acids in CDR-H3. Support for this view comes from studies in human where 
Dµ protein is not made, yet RF2 is still underrepresented in CDR-H3 (7); and from 
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enrichment for CDR-H3s with RF2 encoded amino acids among immunoglobulins from a 
λ5, and thus preBCR-deficient, patient (12).
To test whether amino acids encoded by RF2 are subject to selection by the preBCR 
checkpoint, we took advantage of our panel of BALB/c mice with homozygous gene-
targeted DH alleles (13). The ΔD-DFL DH allele contains a single wild-type DFL16.1 gene 
segment, which is the most frequently used DH. The ΔD-DµFS DH allele contains a single, 
frameshifted DFL16.1 that favors the use of RF2 since the ATG Dµ start codon is in frame 
with RF1 and RF3 still contains a stop codon (Fig. S2). Twenty percent of mature B cells in 
wild-type mice use RF2, while 30% of ΔD-DFL and 60% of ΔD-DµFS B cells use this 
reading frame (14). Thus, B cells in our panel create Ig CDR-H3s with a progressive 
increase in use of RF2 (13), which allowed us to test whether increased use of RF2 encoded 
amino acids influenced successful passage through the preBCR checkpoint.
Results
Increasing the use of RF2 encoded amino acids reduces preBCR expression
We used the scheme of Hardy and Hayakawa (2) to identify progenitor B cell subsets in 
bone marrow. Fraction B contains proB cells that express SLC proteins and are undergoing 
H chain rearrangement; Fraction C contains early preB cells that express µHC and SLC; 
Fraction C’ contains larger early preB cells where successful expression of preBCR is 
associated with cell division; and Fraction D contains late preB cells that no longer express 
SLC and are undergoing L chain rearrangement.
We examined preBCR formation, cell cycling, and apoptosis in fractions B through D from 
WT, ΔD-DFL, ΔD-DµFS, and λ5-deficient (λ5KO) mice, using the latter as a control for the 
absence of a preBCR. Among these mice, increased incorporation of RF2-encoded amino 
acids was associated with diminished preBCR formation, reduced cell division, and 
enhanced apoptosis; each a hallmark of failure to pass the preBCR QC checkpoint.
To assess preBCR expression, we used µHC-specific polyclonal antibodies and a 
monoclonal antibody that only recognizes a completely formed preBCR and not its separate 
components (15). Because cell surface preBCR expression is limited, intracellular staining 
techniques were used (Fig. S3). When compared to WT mice (n=8), there was a major 
decrease in the frequency of preBCR expressing preB cells among ΔD-DµFS fractions C and 
C’ (p=0.003 and p<0.0001, n=8, t test) (Fig. 1A). The ΔD-DFL preB cells were intermediate 
between WT and ΔD-DµFS (p=0.03 and p=0.0003, n=8, t test). in Fraction C and C’, 
respectively), which correlated with the more frequent use of RF2 with this gene segment 
when compared to the other DH (14).
Increasing the use of RF2 encoded amino acids decreases preB cell proliferation
When compared to wild-type littermate controls, we previously found that while ΔD-DFL 
and ΔD-DµFS mice had normal absolute numbers of early preB cells [Fraction C (C+C’)], 
there was a 17% and 40% reduction in the absolute number of late preB cells, respectively 
(13). To assess cell division, we evaluated BrdU incorporation after intraperitoneal injection 
(Fig. S4). Increased use of RF2 correlated with a decrease in BrdU incorporation (Fig. S5A). 
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In all four Hardy fractions studied, WT mice incorporated the most BrdU. ΔD-DFL cells 
were similar to WT or intermediate between WT and ΔD-DµFS, depending on the fraction 
analyzed. Cell division was significantly reduced among ΔD-DµFS B lineage cells. Indeed, 
BrdU incorporation among Fractions B, C and C’ cells was similar to that observed in λ5-
deficient cells. The BrdU+ cells in Fraction D likely represent preB cells that proliferated 
when they were passing through Fraction C’, since pre-B cells can progress through the 
small pre-B cell stage (from large cycling pre-B cells to immature B cells) in approximately 
5 hours and the mice in our studies were exposed to BrdU for 12 hours (16).
To refine the analysis of cell division, we used 7AAD and BrdU staining to examine cell 
cycling (Fig S6). The hierarchy of cells in S-phase (Fig. 1B) correlated with total BrdU 
incorporation (Fig. S5A); more WT than ΔD-DµFS or λ5KO preB cells were replicating. 
The average frequency of replicating ΔD-DFL preB cells tracked with WT but individual 
mice demonstrated a greater variance than those from the other three strains. The hierarchy 
of G0 quiescent cells was complementary. ΔD-DµFS and λ5KO preB cells were more 
quiescent than WT, and ΔD-DFL preB cells were either similar to WT or intermediate 
between WT and ΔD-DµFS (Fig. S5B).
Increasing the use of RF2 encoded amino acids increases preB cell apoptosis
Since apoptosis is a mark of failure to pass the preBCR QC checkpoint, we used staining 
with Annexin V to quantify this process in the different mouse strains. Among proB cells, 
which have not yet reached the preBCR checkpoint, the percentage of Annexin V+ cells was 
similar (Fig. 1C). Among both early and late preB cells, however, more ΔD-DµFS than wild-
type cells were undergoing apoptosis. For ΔD-DFL, apoptosis was similar to wild-type in 
early preB cells and then increased among late preB cells, lying intermediate between wild-
type and ΔD-DµFS cells. This suggests that the use of RF2 encoded amino acids in CDR-H3 
is disfavored for preBCR formation and stability.
Selection for CDR-H3 Y101in mice forced to preferentially rearrange into RF2
A key prediction of our hypothesis is that passage through the preBCR checkpoint would be 
associated with changes in the prevalence of particular amino acids within CDR-H3. CDR-
H3 can be divided into a base and a loop, the latter encoded by the D, by N nucleotides, and 
by the amino terminus of the J. It rests on the surface of the V domain and can assume 
multiple conformations. The carboxyl terminus of the loop is enriched for J-encoded amino 
acids and exhibits less sequence diversity. Thus, we focused on the amino acids in the N 
terminal end of CDR-H3, which is primarily encoded by N addition and DH.
Counting from cysteine at position 96 [Protein Data Bank (PDB) numbering], we examined 
amino acids 99 to 103 among a large database of previously published sequences from wild-
type and D-altered mice (13) (Supplemental File 1). Even though CDR-H3 is of variable 
length, position 101 tends to be centrally located in mouse immunoglobulins. Approximately 
two-thirds of the amino acids at 101 were D-derived, one quarter created by N addition, and 
one-tenth were J-encoded.
To assess the contribution of individual amino acids at positions 99–103 pre- and post-
preBCR QC selection, we subtracted the fraction of usage per amino acid in fraction B 
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(proB) from fraction D (late preB) cells (Fig. 2A). No major fractional changes in positional 
amino acid distribution were observed among WT (Fig. 2A). Thus, CDR-H3 amino acid 
prevalence in wild-type B cells passing though the preBCR QC (Fig. 2B) appeared to 
maintain the amino acid preferences initially created by preferential use of DH RF1 (Fig. 
S2).
Unlike WT, in ΔD-DµFS a number of striking differences were observed after preBCR QC 
(Fig. 2C and D). These included selection for tyrosine (RF1) at 101 and 102 and against 
threonine (RF2) and leucine (RF3) at 102. We also observed a decreasing fraction of 
phenylalanine in positions 101 and 102. This suggested that preBCR selection can be 
influenced by specific amino acid usage at particular CDR-H3 positions.
RF2 and RF3 encoded hydrophobic amino acids at CDR-H3 position 101 predispose to 
apoptosis
To better reveal the CDR-H3 molecular determinants for preBCR selection in WT, we 
pooled bone marrow from twenty 8 week old BALB/c mice, stained cells from Hardy 
Fractions C, C’, and D with Annexin V and PI (Fig. S7A), isolated the double positive, late 
apoptotic cell fraction, and used RT-PCR to clone and sequence CDR-H3s in cells that had 
failed preBCR QC (Supplemental File 2). We compared this set of CDR-H3s to those 
previously isolated from live cells of the same fractions (17) and found that apoptotic cells 
were more likely to use amino acids encoded by RF2 or RF3 (Fig. S7B).
A comparison of CDR-H3 sequences in living and apoptotic Fraction C early preB cells 
revealed that apoptotic cells exhibited increased use of glycine (RF1) at position 100. The 
presence of glycine precludes the formation of side chain interactions. Living cells 
demonstrated increased use of tyrosine and glycine (RF1) at 101; decreased use of leucine 
(RF3) at 101; and decreased threonine (RF2) at 102 and 103 (Fig. 3A, D). Tyrosine provides 
a bulky, flexible side chain that permits changes in conformation as well as a terminal 
hydroxyl group that permits hydrogen bonding. Threonine has a hydroxyl group, but lacks 
the bulky side chain. Leucine is hydrophobic and does not engage in hydrogen bonding with 
side-chain atoms. When compared to Fraction C’ apoptotic cells, living Fraction C’ cells 
exhibited an increase in tyrosine (RF1) and a decrease in glycine (RF1) and leucine (RF3) at 
position 100; and an increase in tyrosine (RF1) alone at 101 (Fig. 3B, D). These differences 
were magnified when compared to Fraction C apoptotic cells (Fig. 3C, D). These findings 
supported the hypothesis that amino acids encoded by RF2 and RF3 were disfavored and 
amino acids encoded by RF1, especially tyrosine, were favored for successful preBCR 
formation.
CDR-H3 Y101 has a beneficial effect on passage through the preBCR quality control 
checkpoint
To gain further insight into the mechanism by which highly prevalent amino acids at specific 
CDR-H3 positions might be selected, we examined the crystal structure of the preB receptor 
(PDB:2H32, Fig. 4A). This is a human preBCR structure and contains serine at position 59. 
We modeled the murine preBCR CDR-H3 SS by replacing human S59 with murine H59. 
CDR-H3 in this structure contains tyrosines at positions 100 through 103, all of which 
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interact with the VpreB CDR-H3 SS. Of these, Y101 forms the most extensive hydrogen 
bond network and van der Waals contacts, with its hydroxyl group positioned for 
interactions with VpreB R51, D57, and R101. The side chains of the three conserved SLC 
CDR-H3 SS residues (Fig. S1) form a pocket that can bind tyrosine at CDR-H3 position 101 
(Fig. 4A), and the main chain hydroxyl group of VpreB R101 can form a hydrogen bond 
with CDR-H3 Y103. Finally, analysis of the original human pre-B cell receptor complex and 
the modeled murine CDR-H3 SS predicts that CDR-H3 Y102 may form a hydrogen bond 
with mouse VpreB H59.
Our experimental data support a role for invariant VpreB in selecting for µHC that contain a 
tyrosine at position 101. To test the structural and functional consequences of this selection, 
we generated and then analyzed molecular models of preBCR structures that used CDR-H3s 
cloned from the living and apoptotic preB cells (Fig. 4B,C, D). We estimated the 
contribution of tyrosine at CDR-H3 positions 101, 102 and 103 to preBCR formation in 
sequences from living C and C’ preB cells that either lacked or contained tyrosine (Fig. 4C, 
top panel). We compared the probability of interaction (fraction of models with at least one 
hydrogen bond) with the VpreB CDR-H3 SS (see Supplementary Materials). To avoid the 
potential confounding factor of runs of tyrosines, we focused this site-specific analysis on 
those sequences with tyrosine at the position of interest that lacked flanking tyrosines (1 left, 
1 right). At positions 101 and 103, the distribution of the probability of interaction with the 
CDR-H3 SS when tyrosine is present (black) or not (white) achieved significance (p < 0.01 
and p = 0.03, respectively; Kolmogorov-Smirnov; Table S1) (Fig. 4C, top panel).
We then grouped the sequences from WT living and apoptotic C and C’ preB cells into those 
with either < 5% or ≥ 5% of the models predicting one or more hydrogen bonds between 
amino acids 101–103 and the CDR-H3 SS (Table S2). CDR-H3 position 103 showed the 
highest fraction of interacting sequences (Fig. 4C, top panel), possibly due its ability to form 
a hydrogen bond with the main chain of VpreB R101 (Fig. 4A). However, the most 
significant differences between the modeled preBCR structures from apoptotic C and those 
from living C and C’ sequences were at position 101 (p= 0.04 and 0.01, respectively; one-
tail Fisher’s exact test; Table S3) (Fig. 4C, bottom panel). Thus, while the presence of a 
tyrosine at either 101 or 103 significantly increases the probability of forming hydrogen 
bonds with VpreB, the major differences between the apoptotic and living cells reflected the 
interaction of the CDR-H3 SS with CDR-H3 position 101.
The importance of position 101 is illustrated in a comparison of the models of a living C’ 
sequence that uses the same VH7183-10 gene segment as an apoptotic C sequence (Fig. 4D). 
The CDR-H3s from these sequences differ in length by only one amino acid. When 
superimposed, their structures show a Root Mean Square Deviation (RMSD) of only 1.5 Å 
for the modeled structures as a whole, and 3.5 Å for the CDR-H3 region (Fig. S8). CDR-H3 
Y101 in the modeled living cell sequence is adjacent to VpreB R51, D57, and R101; and 
Y102 is adjacent to VpreB H59 (Fig. 4B, D). Conversely, CDR-H3 L101 in the modelled 
apoptotic cell sequence is distant from VpreB even though CDR-H3 R102 is adjacent to 
VpreB R101 (Fig. 4D).
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Further support for the beneficial effect of Y101 on passage through the preBCR QC derives 
from the distribution of amino acids at CDR-H3 101 in the sequences from living versus the 
apoptotic cells (Fig. 3). Y101 proved more common in living C’ sequences than in apoptotic 
C (p=0.005; one-tail Fisher’s exact test; Table S4) (Fig. 3C). Conversely, L101, which is 
frequently encoded by RF3, is more common in apoptotic C than in living C (p= 0.02, one-
tail Fisher’s exact test; Table S5) (Fig. 3A) [Details regarding the comparative modeling 
protocol used for predicting the structures and their structural comparisons are reported in 
the supplementary material.]
In IgG Fab:antigen crystal structures, CDR-H3 Y101 often interacts with antigen
Having shown that CDR-H3 tyrosines, in particular Y101 are selected for and interact with 
VpreB during early B cell development, we next investigated the role of these tyrosines in 
the interaction of the Fab with antigen, using the IMGT database to identify a set of 133 
non-redundant murine antigen:Fab crystal structures in the Protein Data Bank (Supplemental 
File 3) (http://www.pdb.org). A comparison of the distribution of amino acids at positions 99 
through 103 revealed that G99 was preferred in the IgG Fabs rather than H99, which was 
more prevalent in the living progenitor B cells (Figs. 2B, 3D, and 5A). In positions 100–103, 
however, both the preimmune living progenitor B cells and the antigen selected IgGs 
demonstrated the same preference for G100, Y101, Y102 and Y103 (Fig. 5A).
We examined the IgG:antigen crystal structures to determine which CDR-H3 residues used a 
hydrogen bond to engage with antigen (Fig 5B) or L chain. We found that the 101–103 
tripeptide (101,102,103) was more likely to engage antigen (65% of cases) than L chain 
(42%) (Table S6). As above, we then considered only the structures with a tyrosine at 101, 
102 or 103 that lacked flanking tyrosines. At positions 101 and 103, structures that use 
tyrosine (black bar) were significantly more likely to engage antigen with a hydrogen bond 
than structures with residues other than tyrosine (white bar) (p = 0.008, one-tail Fisher’s 
exact test; Table S7) (Fig. 5C). No significant preferences for specific amino acid 
composition were found for structures binding L chain, which is more likely to engage 
CDR-H3 at position 103 than position 101 (Table S8).
Discussion
µHCs in late preB cells have access to an array of diverse L chains. Thus, the only time 
during B cell development when the L chain partner is invariant occurs at the preBCR QC 
checkpoint. Here we provide evidence that this checkpoint not only selects for cells 
expressing µHC able to bind to a conventional L chain, but also selects for the use of 
particular amino acids at specific positions at the center of the antigen binding site, where 
they can subsequently influence antigen recognition and antibody production. This selection 
process appears to begin just after the µHC is created, in the endoplasmic reticulum (ER) of 
the early preB cell. Presence of a CDR-H3 that cannot bind effectively to the CDR-H3 SS of 
the SLC would result in retention of the µHC by ER chaperones and failure to form a 
preBCR, resulting in decreased cell proliferation and increased cell loss by apoptosis.
Although not identical, the level of sequence similarity (>70%) between human and mouse 
VpreB suggests that the selection mechanisms described in mouse may also be used in 
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human to regulate CDR-H3 amino acid content and reading frame usage (4). We have shown 
that changing of the pattern of DH reading frame usage, and thus the prevalence of tyrosine 
in CDR-H3, in mice alters patterns of epitope recognition after vaccination with HIV gp140 
(6). It is possible that the binding instability of SLC to µHCs containing CDR-H3s with 
amino acids commonly encoded by non-tyrosine enriched reading frames may help explain 
the difficulty experienced by HIV patients in generating neutralizing antibodies that require 
CDR-H3 amino acids typically encoded by RF2 or RF3.
We have previously shown that natural selection of germline DH sequence creates a bias in 
global CDR-H3 amino acid content that is established at the time of VDJ rearrangement 
prior to antigen exposure (17). The presence of other tyrosines around position 101 and their 
possible interactions with VpreB support the hypothesis that the binding of CDR-H3 to the 
SLC is a stochastic process in which specific amino acids increase the chance of forming 
hydrogen bonds that stabilizes the preBCR.
Although among individual structures the likelihood of interactions between the antigen and 
individual CDR-H3 residues can be influenced by the length of the CDR-H3 loop, our 
observations support the global hypothesis that CDR-H3 residue 101 and 103 often play an 
important role, especially in the presence of tyrosine, in binding both the VpreB in the 
preBCR (Fig. 4D) and in binding the antigen in the IgG:antigen complex (Fig. 5C). High 
throughput sequencing of H chains from developing preB cells from the WT and D-altered 
mice would enable enhanced comparisons of CDR-H3s of similar length.
Both natural selection of DH germline sequence and passage through the preBCR checkpoint 
promote the inclusion of a tyrosine at CDR-H3 position 101. However, our results do not 
exclude alternative interaction patterns in which amino acids with similar chemico-physical 
properties can form stable preBCR. In our view, the CDR-H3 regions from apoptotic cells 
correspond to amino acids combinations with a low probability of forming hydrogen bonds 
with VpreB R51/D57/R101 component of the CDR-H3 sensing site and thus creating a 
functional preBCR with an H chain antigen binding site optimized for binding antigen. An 
analysis of repertoire selection and responses to antigenic challenges in mice where 
sequence of the CDR-H3 SS has been mutated would provide confirmation of this 
interpretation.
In summary, the sequence of the DH has a positional effect, selecting for particular amino 
acids at specific locations within the antigen binding site (Fig 2) (6). In this work, we show 
that selection of CDR-H3 by the VpreB portion of SLC reinforces the positional bias in 
amino acid content, which is consistent with the bias in antigen-binding IgG. Our findings 
suggest that the molecular mechanism underlying the selection of CDR-H3 Y101 is the 
stabilization of the preBCR by the creation of hydrogen bonds between Y101 and VpreB 
R51/D57/R101. Analysis of the crystal structures of IgG Fab:antigen complexes indicates 
that the CDR-H3 residues selected by VpreB are ultimately more likely to form hydrogen 
bonds with antigen than L chain. The combination of natural selection of DH sequence and 
somatic selection by invariant surrogate light chain favors the presence of tyrosine at key 
positions in the antigen binding site, thus shaping the antigen specificity of the primary 
(IgM) and secondary (IgG) humoral response.
Khass et al. Page 9
Sci Immunol. Author manuscript; available in PMC 2017 February 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Materials and Methods
Study design
We sought to determine whether preBCR expression, progenitor B cell division, and 
progenitor B cell apoptosis was influenced by the amino acid sequence of immunoglobulin 
CDR-H3 during B cell development by analyzing a panel of BALB/c mouse strains that had 
been gene targeted in their DH locus and thus expressed a gradient of altered amino acid 
sequence. We then performed a combined sequence structural analysis of H chains cloned 
from living and apoptotic progenitor B cells to test for positional patterns of amino acid 
preference and compared the results to IgG Fab:antigen structures that were publically 
available.
All data obtained from the mice is presented, including outliers. We used six or more mice 
per group. The genotypes were not blinded and randomization was not performed. All of the 
modeled H chains cloned from early preB cells were unique. To select a representative set of 
structures we queried the IMGT database (http://www.imgt.org/) searching for Mus 
musculus Fab with protein antigen and resolution ≤3.5 Å. From this initial group of 
structures we selected the PDBs with heavy chains sequence similar to our set of VH 7183 
family members. The sequence similarity was detected using the BLAST algorithm (18) 
using an e-value threshold of 10–3. Redundant PDBs were removed selecting only the 
representative structures of each cluster defined using a 95% sequence similarity threshold 
(ftp://resources.rcsb.org/sequence/clusters/clusters95.txt). The final set of 133 Fab:antigen 
PDB structures is provided in Supplemental File 3.
Mice
All experiments and animal procedures were performed using protocols approved by the 
University of Alabama Institutional Animal Care and Use Committee (IACUC). BALB/c 
mice were bred under specific pathogen free conditions in the UAB vivarium. The ΔD-DFL 
and ΔD-DµFS D-altered mice were generated on a BALB/c background as described 
previously (14, 19). λ5KO mice, originally on a C57BL/6 background (20), were 
backcrossed for 22 generations onto BALB/c.
Flow cytometry analysis of bone marrow B cell subsets
Single cell suspensions were prepared from femurs of 8 week old mice as previously 
described (7). Cells were washed, stained, and analyzed on an LSRII (BD Biosciences) 
using the following labeled antibodies: anti-B220 (PB), anti-CD19 (APC-Cy7), anti-CD43 
(Biotin), anti-BP-1 (PE), and anti-IgM (APC) from BD Pharmingen; anti-AA4.1 (PE-Cy7) 
from eBioscience; and anti-IgD (Biotin) from Southern Biotech. Propidium Iodide (PI) was 
used to identify dead cells. The scheme of Hardy (2) was used to identify different B cell 
subsets in the BM. Fractions C and C’ were distinguished based on cell size.
Intracellular evaluation of binding of µHC to SLC
PreB cell subsets in the BM, as identified by the expression of relevant surface markers, 
were fixed using a Cytofix/Cytoperrm kit [BD Pharmingen] and then stained for intracellular 
preBCR using a pre BCR mAb (clone SL156) [BD Pharmingen] and goat anti-mouse µHC 
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(FITC) (Southern Biotech) (Fig 1A). Successful formation of preBCR was defined by dual 
staining with both antibodies, as described by Kawano et al. (15) (Fig. S3).
Bromodeoxyuridine labeling
Bromodeoxyuridine (BrdU) incorporation was used to assess B cell proliferation. BrdU was 
administered by intraperitoneal injection (1 mg/mouse) twice daily at 12 hour intervals. 
Twelve hours after the last injection, mice were sacrificed, BM cells were washed, fixed and 
BrdU positive B cells were detected with antibodies specific for BrdU using the BrdU-flow 
kit [BD Biosciences] according to the manufacturer’s protocol (Fig. S4).
Cell cycle analysis
Bone marrow B cell subsets were analyzed for cell cycle progression using BrdU and 7AAD 
staining according to the BrdU-flow kit [BD Biosciences]. Cell cycle stages were identified 
as: G0-phase, quiescent cells (BrdU negative and 7AAD negative), G1-phase, cells 
preparing for cycling (BrdU positive and 7AAD negative), S-phase, proliferating cells (BrdU 
positive and 7AAD positive) and G2-M-phase cells in process of finishing cycling (BrdU 
intermediate and 7AAD positive) (Figs 1B, S4, 5 & 6)
Evaluating the extent of apoptosis in different B cell subsets
The frequency of apoptosis in different B cell subsets in the BM was determined based on 
Propidium Iodide (PI) and Annexin V staining using the FITC Annexin V Apoptosis 
Detection Kit II [BD Biosciences]. Late apoptotic cells that express both Annexin V and PI 
were sorted for CDR-H3 cDNA construction, sequencing (as described below) and structural 
modeling as they represent a true indicator of fully apoptotic cells (Figs. 1C & S7).
Flow cytometric sorting, RNA preparation, RT-PCR and sequencing
Living and late apoptotic preB cells were sorted based on expression of surface markers (2) 
using the FACSAria cell sorter [BD Biosciences]. Total RNA was isolated and converted to 
cDNA using VH7183 specific VDJCµ RT-PCR primers. Clones positive for an insert of the 
appropriate size were sequenced and analyzed as previously described (14, 21, 22). A list of 
the unique, in-frame sequences used for analysis in this work is provided in Supplemental 
File 2.
Dataset for structural modeling
Total living and apoptotic cells were collected without bias. Sequence/structure-function 
relationships were determined using potential differences in the predicted structures obtained 
from living and apoptotic cells. We examined 31 and 39 unique sequences from apoptotic C 
and C’, and 83 and 36 sequences from living C and C’, respectively. The 189 CDR-H3 
sequences are reported in Supplemental File 2.
Sequence analysis of the CDR-H3 regions
CDR-H3 was defined as the sequence starting immediately after the cysteine at the end of 
FR3 at position 96 and then through, but not including, the tryptophan that begins FR4. At 
positions 99 through 103, we calculated the frequency of the amino acids in individual 
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developing B cell subsets. The residues are grouped in three main categories according to 
their hydrophobicity as assessed in the Kyte-Doolittle scale as modified by Eisenberg (23, 
24). Under this scheme arginine, lysine, asparagine, aspartic acid, glutamine, glutamic acid 
and histidine are considered charged and shown in red; proline, tryptophan, serine, threonine 
and glycine are considered neutral or hydrophilic and shown in green; and alanine, 
methionine, cysteine, phenylalanine, leucine, valine, and isoleucine are considered 
hydrophobic and shown in blue. Tyrosine, which is the most abundant residue in our dataset 
(~21%), is normally included among the hydrophilic, neutral fraction. For this work, 
tyrosine was counted separately and is shown in black for emphasis. The amino acid 
composition in the different positions was displayed using WebLogo (http://
weblogo.berkeley.edu/) (25).
Structural analysis of the predicted preB cell receptor models
To study the structural and functional features of the CDR-H3 region, we predicted the 
structure of the mouse pre-B cell receptor using homology modeling (26) using the structure 
of the human pre-B cell receptor (PDB: 2H32) as a template (4). The structure of this protein 
complex is a trimer containing VpreB, λ5 and immunoglobulin µHC.
All the murine preBCR models were then generated using the sequences of the mouse Vpre1 
(SwissProt: VPRE1_MOUSE) and λ5 (SwissProt: IGLL1_MOUSE). Each model of the 
pre-B cell receptor complex differs in the sequence of the Ig heavy chain, which is 
assembled using the different VH 7183 family members with unique CDR-H3s. Global 
alignments were calculated using align (27) using default parameters without end gap 
penalties. The sequence identities between human and mouse sequences are 77% for VpreB, 
65% for λ5 and in the range of 40–58% for µHC depending on the specific VH183 family 
member (see alignments in Supplemental File 4).
Mouse pre-B protein structures were predicted using MODELLER (28). We generated 50 
models for each sequence in our dataset. These were used to predict the interactions between 
the CDR-H3 regions, VpreB and µ5 in the pre-B cell receptor complex. An example of a 
comparison between two similar predicted structures of µHC sequences from living C’ 
(cyan) and apoptotic C (magenta) cells is shown in Fig. 4B,D and Fig. S8. We analyzed the 
region surrounding CDR-H3 residues 101 through 103 and their possible interaction with 
VpreB residues. A hydrogen bond was predicted considering a distance threshold of 3.5 Å 
between two electronegative atoms (N, O). For each CDR-H3 sequence we calculated the 
probability of interacting models (IM) in a given position as the fraction of models in which 
a hydrogen bond was detected. To evaluate the importance of tyrosine in residues 101–103 
and to reduce the bias of consecutive tryrosines, we evaluated a subset of sequences with and 
without tyrosine in the central position without flanking tyrosines. The analysis of this 
subset of sequences from living C and C’ cells is reported in the top panel of Fig. 4C. We 
then focused only on position 101 and considered the fraction of sequences forming a 
hydrogen bond (HB) with CDR-H3 SS in at least 5% of the models (blue bar, HB≥5%) 
compared with the fraction of sequences that engaged in hydrogen bond in less than 5% of 
the models (red bar, HB<5%), across living and apoptotic fraction C and C’ sequences (Fig. 
4C, bottom panel). The significance in the difference of the predicted hydrogen bonds in 
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position 101 was estimated by one-tail Fisher’s exact test. All the PDB files of the predicted 
models are available in Supplemental File 5.
Structural analysis of the Fab:antigen PDB structures
Finally, we performed an analysis of murine Fab:antigen PDB structures. The structures 
were analyzed calculating the hydrogen bonds using a distance threshold of 3.5 Å between 
two electronegative atoms (N, O). To estimate the importance of tyrosine in the formation of 
hydrogen bonds in positions 101–103 we compared the fraction interacting and non-
interacting structures with and without tyrosine in a given position. The bias for consecutive 
tyrosines was reduced considering the subset of sequences without flanking tyrosines around 
the central position. The result of this analysis is reported in Fig. 5C.
Statistical analyses
Differences between populations or groups were assessed by Student’s t-test, one- tailed; 
Fisher’s exact test, two tailed; the Levene test for the homogeneity of variance; the 
Kolmogorov-Smirnov test, or the non-parametric Mann-Whitney test. A p-value (p) of less 
than 0.05 was considered significant. JMP version 12 (SAS Institute Inc.) was used for 
analysis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank S. Louis Bridges, Harry W Schroeder III, and Robert R. Rich for helpful discussions. We thank Leticia 
Watkins, Cun Ren Liu and Yingxin Zhuang for expert technical assistance.
Funding:
The present study was supported by the US National Institutes of Health (NIH) AI048115, AI049342, AI090902, 
AI090742, AI097629, and AI117703. Flow cytometry was supported by NIH AR48311 and AI027767. Modeling 
studies were supported by funds provided by the Department of Pathology, University of Alabama at Birmingham 
and computational resources of the Geneifx - Genome Informatics Service.
References
1. Melchers F. Checkpoints that control B cell development. J Clin Invest. 2015:1–8. [PubMed: 
25654544] 
2. Hardy RR, Hayakawa K. B cell development pathways. Ann Rev Immunol. 2001; 19:595–621. 
[PubMed: 11244048] 
3. Narciso JE, Uy ID, Cabang AB, Chavez JF, Pablo JL, Padilla-Concepcion GP, Padlan EA. Analysis 
of the antibody structure based on high-resolution crystallographic studies. Nat Biotechnol. 2011; 
28:435–447.
4. Bankovich AJ, Raunser S, Juo ZS, Walz T, Davis MM, Garcia KC. Structural insight into pre-B cell 
receptor function. Science. 2007; 316:291–294. [PubMed: 17431183] 
5. Kim ST, Shirai H, Nakajima N, Higo J, Nakamura H. Enhanced conformational diversity search of 
CDR-H3 in antibodies: role of the first CDR-H3 residue. Proteins. 1999; 37:683–696. [PubMed: 
10651282] 
Khass et al. Page 13
Sci Immunol. Author manuscript; available in PMC 2017 February 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
6. YK Wang P, Parks R, Silva-Sanchez A, Alam SM, Verkoczy L, Liao HX, Zhuang Y, Burrows PD, 
Levinson M, Elgavish A, Cui X, Haynes BF, Schroeder HW Jr. HIV-1 gp140 epitope recognition is 
influenced by immunoglobulin DH gene segment sequence. Immunogenet. 2016; 68:145–155.
7. Ivanov, II., Link, JM., Ippolito, GC., Schroeder, HW, Jr. The Antibodies. Zanetti, M., Capra, JD., 
editors. Vol. 7. London: Taylor and Francis Group; 2002. p. 43-67.
8. Gu H, Kitamura D, Rajewsky K. DH reading frame bias: evolutionary selection, antigen selection or 
both? Evolutionary selection. Immunol Today. 1991; 12:420–421. [PubMed: 1786075] 
9. AL Silva-Sanchez CR, Vale AM, Khass M, Kapoor P, Elgavish A, Ivanov II, Ippolito GC, Schoeb T, 
Burrows PD, Schroeder HW Jr. 2015
10. Zemlin M, Schelonka RL, Ippolito GC, Zemlin C, Zhuang Y, Gartland GL, Nitschke L, Pelkonen J, 
Rajewsky K, Schroeder HW Jr. Regulation of repertoire development through genetic control of D 
H reading frame preference. J Immunol. 2008; 181:8416–8424. [PubMed: 19050259] 
11. Khass M, Buckley K, Kapoor P, Schelonka RL, Watkins LS, Zhuang Y, Schroeder HW Jr. 
Recirculating bone marrow B cells in C57BL/6 mice are more tolerant of highly hydrophobic and 
highly charged CDR-H3s than those in BALB/c mice. Eur J Immunol. 2013; 43:629–640. 
[PubMed: 23225217] 
12. Minegishi Y, Conley ME. Negative selection at the pre-BCR checkpoint elicited by human mu 
heavy chains with unusual CDR3 regions. Immunity. 2001; 14:631–641. [PubMed: 11371364] 
13. Schroeder HW Jr, Zemlin M, Khass M, Nguyen HH, Schelonka RL. Genetic control of DH reading 
frame and its effect on B-cell development and antigen-specifc antibody production. Crit Rev 
Immunol. 2010; 30:327–344. [PubMed: 20666706] 
14. Schelonka RL, Ivanov II, Jung D, Ippolito GC, Nitschke L, Zhuang Y, Gartland GL, Pelkonen J, 
Alt FW, Rajewsky K, Schroeder HW Jr. A single DH gene segment is sufficient for B cell 
development and immune function. J Immunol. 2005; 175:6624–6632. [PubMed: 16272317] 
15. Kawano Y, Yoshikawa S, Minegishi Y, Karasuyama H. Selection of stereotyped VH81X-{micro}H 
chains via pre-B cell receptor early in ontogeny and their conservation in adults by marginal zone 
B cells. Int Immunol. 2005; 17:857–867. [PubMed: 15908445] 
16. Casellas R, Shih TA, Kleinewietfeld M, Rakonjac J, Nemazee D, Rajewsky K, Nussenzweig MC. 
Contribution of receptor editing to the antibody repertoire. Science. 2001; 291:1541–1544. 
[PubMed: 11222858] 
17. Ivanov II, Schelonka RL, Zhuang Y, Gartland GL, Zemlin M, Schroeder HW Jr. Development of 
the expressed immunoglobulin CDR-H3 repertoire is marked by focusing of constraints in length, 
amino acid utilization, and charge that are first established in early B cell progenitors. J Immunol. 
2005; 174:7773–7780. [PubMed: 15944280] 
18. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST 
and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997; 
25:3389–3402. [PubMed: 9254694] 
19. Schelonka RL, Zemlin M, Kobayashi R, Szalai A, Ippolito GC, Zhuang Y, Gartland GL, Fujihashi 
K, Rajewsky K, Schroeder HW Jr. Preferential use of D H reading frame 2 alters B cell 
development and antigen-specific antibody production. J Immunol. 2008; 181:8409–8415. 
[PubMed: 19050258] 
20. Kitamura D, Kudo A, Schaal S, Muller W, Melchers F, Rajewsky K. A critical role of lambda 5 
protein in B cell development. Cell. 1992; 69:823–831. [PubMed: 1591779] 
21. Ivanov II, Schelonka RL, Zhuang Y, Gartland GL, Zemlin M, Schroeder HW Jr. Development of 
the expressed Ig CDR-H3 repertoire is marked by focusing of constraints in length, amino acid 
use, and charge that are first established in early B cell progenitors. J Immunol. 2005; 174:7773–
7780. [PubMed: 15944280] 
22. Ippolito GC, Schelonka RL, Zemlin M, Ivanov II, Kobayashi R, Zemlin C, Gartland GL, Nitschke 
L, Pelkonen J, Fujihashi K, Rajewsky K, Schroeder HW Jr. Forced usage of positively charged 
amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production. J 
Exp Med. 2006; 203:1567–1578. [PubMed: 16754718] 
23. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol 
Biol. 1982; 157:105–132. [PubMed: 7108955] 
Khass et al. Page 14
Sci Immunol. Author manuscript; available in PMC 2017 February 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
24. Eisenberg D. Three-dimensional structure of membrane and surface proteins. Annu Rev Biochem. 
1984; 53:595–623. [PubMed: 6383201] 
25. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome 
Res. 2004; 14:1188–1190. [PubMed: 15173120] 
26. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A. Comparative protein structure 
modeling of genes and genomes. Annu Rev Biophys Biomol Struct. 2000; 29:291–325. [PubMed: 
10940251] 
27. Huang X, Miller M. A time-efficient, linear-space local similarity algorithm. Adv. Appl. Math. 
1991; 12:337–357.
28. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, Pieper U, Sali A. 
Comparative protein structure modeling using Modeller. Current protocols in bioinformatics / 
editoral board, Andreas D. Baxevanis ... [et al.]. 2006 Chapter 5, Unit 5 6. 
Khass et al. Page 15
Sci Immunol. Author manuscript; available in PMC 2017 February 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. Increasing the use of RF2-encoded amino acids in CDR-H3 diminishes preBCR 
formation, decreases cell cycling, and enhances apoptosis
Among progenitor B lineage cells: (A) Percent of preBCR positive cells. The cells were 
intracellularly stained with µ HC-specific polyclonal antibodies and with the SL156 
monoclonal preBCR-specific antibody that detects a conformational epitope on the complete 
preBCR. Cells stained with both antibodies were counted as pre BCR+. (B) Percent of cells 
in S-phase as determined by BrdU incorporation. (C) Percent of cells undergoing apoptosis 
as determined by Annexin V staining. Each dot indicates a measurement from an individual 
mouse. Dots are grouped by mouse strain (WT, ΔD-DFL, ΔD-DµFS, and λ5) and B cell 
developmental stage.
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Fig. 2. CDR-H3 amino acid usage by position in proB (Fraction B) versus late preB (Fraction D) 
cells
(A, C) Fractional difference in the percent usage of individual amino acids between WT (A) 
and ΔD-DµFS (C) CDR-H3s at positions 99 to 103. Amino acids are arranged by 
hydrophobicity in the order of R, K, N, D, Q, E, H, P, Y, W, S, T, G, A, M, C, F, L, V, and I. 
(B, D) CDR-H3 amino acid usage by percentage rank order. The list of CDR-H3 sequences 
from WT and ΔD-DµFS cells in fractions B and D is reported in Supplemental File 1.
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Fig. 3. CDR-H3 amino acid usage by position from wild-type living and apoptotic early preB 
cells
(A-C) Fractional difference in the percent usage of individual amino acids between CDR-H3 
sequences cloned from apoptotic and living fraction C and C’ preB cells at positions 99 
through 103. Amino acids are arranged by hydrophobicity as in Figure 2. (D) CDR-H3 
amino acid usage by percentage rank order. The list of CDR-H3 sequences from living and 
apoptotic cells in fractions C and C’ is reported in Supplemental File 2.
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Fig. 4. Analysis of predicted preB cell receptor complex structures
(A) Structure of the murine preBCR obtained by modeling the H59 sidechain, which is a 
serine in the human VpreB structure (PDB: 2H32). VpreB is in green and CDR-H3 residues 
99–103 are in cyan. (B) Example of a predicted structure of a mouse preB cell receptor 
complex from a wild-type living C’ sequence. VpreB is in green, λ5 in gray, and the H chain 
V domain in cyan. (C) Analysis of the preBCR models from CDR-H3 sequences in living C 
and C’ cells. The top panel shows the fraction of interacting models (IM) for the subset of 
structures with (black, Y) and without (white, Not Y) tyrosine in the indicated CDR-H3 
position for those sequences without a tyrosine flanking that position. In the bottom panel, 
we compared the percentage of sequences from living and apoptotic C/C’ cells forming a 
hydrogen bond (HB) with CDR-H3 SS at position 101 only in at least 5% of the models 
(blue bar, HB≥5%), with sequences which engage in hydrogen bond with position 101 in 
less than 5% of the models (red bar, HB<5%). (D) Comparison of the predicted structures of 
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two almost identical VDJCµ sequences from living C’ and apoptotic C cells that use the 
same VH7183-10 gene segment and differ only in CDR-H3. The predicted interactions 
between the SLC CDR-H3 SS (green) and the CDR-H3 region from a living C’ cell (left, 
cyan) and an apoptotic C’ cell (right, magenta).
Khass et al. Page 20
Sci Immunol. Author manuscript; available in PMC 2017 February 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 5. Analysis of the CDR-H3 region in murine IgG Fab:antigen PDB structures
(A) Amino acid composition of CHR-H3 regions at position 99–103 in the 133 analyzed 
structures. (B) Example of CDR-H3 Y101 interacting with antigen (Cytochrome C) in PDB: 
1WEJ. (C) Fraction of structures with (black, Y) and without (white, Not Y) tyrosine in 
CDR-H3 positions 101–103 that form hydrogen bonds with antigen among those sequences 
were the tyrosine in the selected position lacks a flanking (1 left, 1 right) tyrosine. The list of 
Fab:antigen PDB structures used in this analysis is reported in Supplemental File 3. The 
procedure used for selection of the Fab:antigen PDB structures is described in 
Supplementary Materials.
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